Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries
World Health Organization · Public Health England · +41 more institutions
Indexed incrossrefpubmed
Abstract
Latent tuberculosis infection (LTBI) is characterised by the presence of immune responses to previously acquired Mycobacterium tuberculosis infection without clinical evidence of active tuberculosis (TB). Here we report evidence-based guidelines from the World Health Organization for a public health approach to the management of LTBI in high risk individuals in countries with high or middle upper income and TB incidence of
Citation impact
585
total citations
- FWCI
- 41.17
- Percentile
- 100%
- References
- 72
Citations per year
Authors
72- HGHaileyesus GetahunCorresponding
World Health Organization
- AMAlberto Matteelli
World Health Organization
- IAIbrahim Abubakar
Public Health England, University College London
- MAMohamed Abdel Aziz
World Health Organization Regional Office for the Eastern Mediterranean
- ABAnnabel Baddeley
World Health Organization
Topics & keywords
Topics
Keywords
- Medicine
- Latent tuberculosis
- Isoniazid
- Tuberculosis
- Tuberculin
- Rifampicin
- Mycobacterium tuberculosis
- Interferon gamma release assay
No related works found for this paper.